Non-Hodgkin's lymphomas, version 4.2014. - Wikidata - wikimedia - TriplyDB

Non-Hodgkin's lymphomas, version 4.2014.

Non-Hodgkin's lymphomas, version 4.2014.

http://www.wikidata.org/entity/Q36820885

about

Chronic lymphocytic leukemia: a clinical review including Korean cohorts Challenges in the Role of Gammaglobulin Replacement Therapy and Vaccination Strategies for Hematological Malignancy Next-generation surveillance strategies for patients with lymphoma Extranodal NK/T Cell Lymphoma, Nasal Type (ENKTL-NT): An Update on Epidemiology, Clinical Presentation, and Natural History in North American and European Cases.Human immunodeficiency virus-associated lymphomas in the antiretroviral therapy era: Analysis of the National Cancer Data Base.Increased risk for metachronous gastric adenocarcinoma following gastric MALT lymphoma-A US population-based study.Distinct biological subtypes and patterns of genome evolution in lymphoma revealed by circulating tumor DNA.Characteristics of TCRζ, ZAP-70, and FcɛRIγ gene expression in patients with T- and NK/T-cell lymphoma Noninvasive monitoring of diffuse large B-cell lymphoma by immunoglobulin high-throughput sequencing.Hepatitis B Virus Screening for Patients With Cancer Before Therapy: American Society of Clinical Oncology Provisional Clinical Opinion Update.Drug-Free Macromolecular Therapeutics--A New Paradigm in Polymeric Nanomedicines Comparison of Three Chemotherapy Regimens in Elderly Patients with Diffuse Large B Cell Lymphoma: Experience at a Single National Reference Center in Mexico.Pegfilgrastim in primary prophylaxis of febrile neutropenia following frontline bendamustine plus rituximab treatment in patients with indolent non-Hodgkin lymphoma: a single center, real-life experience.GATA3 expression correlates with poor prognosis and tumor-associated macrophage infiltration in peripheral T cell lymphoma Surveillance imaging in mantle cell lymphoma in first remission lacks clinical utility.Hematopoietic progenitor cell mobilization for autologous transplantation - a literature review.The impact of hepatitis B virus infection and vaccination on the development of non-Hodgkin lymphoma.Recommendations for Clinical Trial Development in Mantle Cell Lymphoma.Frontline intensive chemotherapy improves outcome in young, high-risk patients with follicular lymphoma: pair-matched analysis from the Czech Lymphoma Study Group Database.The different roles of molecular classification according to upfront autologous stem cell transplantation in advanced-stage diffuse large B cell lymphoma patients with elevated serum lactate dehydrogenase.MDR1 polymorphisms have an impact on the prognosis of Chinese diffuse large B cell lymphoma patients.Design of smart HPMA copolymer-based nanomedicines.Radiotherapy plus rituximab as first-line regimen for localized follicular lymphoma.Bowel perforation from occult ileal involvement after diagnosis in a case of primary mediastinal large B-cell lymphoma.Haemodynamic instability secondary to cardiac involvement by lymphoma.Durable remission is achievable with localized treatment and reduction of immunosuppression in limited stage EBV-related plasmablastic lymphoma.Treatment patterns and outcomes with subcutaneous bortezomib in patients with relapsed mantle cell lymphoma: a retrospective, observational study of patient medical records from US community oncology practices.Older patients with early-stage diffuse large B-cell lymphoma: the role of consolidation radiotherapy after chemoimmunotherapy.Time, timing, and the treatment of diffuse large B-cell lymphoma.Metabolic tumor volume changes assessed by interval 18fluorodeoxyglucose positron emission tomography-computed tomography for the prediction of complete response and survival in patients with diffuse large B-cell lymphoma.Primary Gastric Lymphoma, Epidemiology, Clinical Diagnosis, and Treatment.

P2860

Q26752467-CEAC14E8-8E5F-4DF6-A5E9-8C63772F5A04 Q28080304-10FF1294-7016-4D3E-93A5-7741FA86A565 Q28084956-E202917B-FA79-42ED-9ECA-1E3DE5A23BE4 Q30244110-CB7B951C-B165-4FF9-996F-FCFB93AF6871 Q31110269-A9605A1A-4CB5-44ED-AA05-5470EFDD4785 Q33732016-5BAD4B1D-FEDD-4E1A-AE5D-8AFF2866DDA5 Q33851726-F5F538A1-2890-41BF-94BA-094932FCB260 Q35110756-AB76A73A-932B-446A-8720-CF5110BF783D Q35723986-52539754-0FDA-4C71-BE4A-FB1C10DC4E23 Q35771194-CB4291CB-033B-4924-8A13-834E8D484EEE Q35861726-71F26D42-2937-427F-B0F5-A045A9279410 Q37120684-8ED0ADBD-C2FF-4D91-8DEB-8CC6BA2637B4 Q37607286-B6C45376-81D3-45A7-8389-D04CC12167B5 Q37662219-E26FA277-6475-475C-8CD4-8EF762F5C4B2 Q38630219-75975EE4-6CAF-49DF-ACDA-12D3DEBBA55A Q38771080-A7E39D36-A065-4460-A7B1-3B0FF5D00BF3 Q38856104-305CFBEB-2C00-43FE-9156-1E72064969BC Q39045701-D3F2A766-3430-44AB-9582-3B3A1BB43E77 Q39353147-1083ED02-329C-4768-B888-BCAF4D840E85 Q39669214-0BC32575-C1C7-4EBB-AC6C-04006D4D950F Q41471555-455A90B1-6C7C-4D6E-AC05-A025D7466F6A Q42553783-917573C1-AF55-44D2-87B5-D82BBEFF9127 Q47830676-39C19F61-B660-49E3-BA59-0BBD04F8F624 Q48158787-025A07BB-CC6F-4D3D-A0C4-69543416317A Q51289951-7CA48146-317A-4304-BB61-8A7C1F57888A Q51824124-E559C7DD-4DEE-4EEA-8A19-7A2BF0A04402 Q52802238-00E84E61-63A1-4AA2-982F-A7CD4CD75A93 Q53019638-84105B13-A47B-4F1E-B10F-FDDE5F10647F Q53435280-96725442-5E5C-497D-AB4C-FC55EB626ABF Q55660635-03826004-D18A-43F0-8052-006A62D4A99D Q55717193-BBC662FB-A4EC-4762-B116-D5713206A1C4

P2860

Non-Hodgkin's lymphomas, version 4.2014.

http://www.wikidata.org/entity/Q36820885

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

2014年论文

@zh

2014年论文

@zh-cn

name

Non-Hodgkin's lymphomas, version 4.2014.

@en

type

label

Non-Hodgkin's lymphomas, version 4.2014.

@en

prefLabel

Non-Hodgkin's lymphomas, version 4.2014.

@en

P1433

Q36820885-D8F2D79A-D254-48C4-B92A-CA96F2EA88F5

P1476

Q36820885-06F4818A-8637-42DC-BC1D-A3AE417A885F

P2093

Q36820885-0053F301-340B-419F-9E1E-152B6A114DD9

Q36820885-07DFF27A-9382-4CE3-B766-FCF768356F09

Q36820885-09DE785B-62E3-4C7F-BB7E-57AAD2A47BDE

Q36820885-15821D68-B89E-4CF2-A218-8AEEAAE611D7

Q36820885-20949B70-0EF4-4609-BF35-F48E5DBDB270

Q36820885-210CAAD7-5EFE-4F6F-A852-4A2B9F81D465

Q36820885-25B8233A-B008-4CEF-A3EE-31C6AE8F432C

Q36820885-28BAC05C-2D69-47BC-BB22-D8486ABC61C3

Q36820885-2A5AAC50-4501-43FB-A164-DDFB54D1DFD8

Q36820885-2C2F3F41-A729-4102-B26D-3C4F1FF63FF6

P2860

Q36820885-08162D09-1A58-43F5-9D8B-0E56658F3C52

Q36820885-0CB02AFF-5417-43F6-AA5E-4BFB996F605D

Q36820885-0F50A30B-91C8-462F-9808-545ABBD60210

Q36820885-1569A5FE-76D1-4867-9625-C7D63E8A305D

Q36820885-1B440C9A-CB0B-4D93-91BE-89E3B262279D

Q36820885-1FAB299F-B750-4240-A8FE-1579F9356532

Q36820885-2651DD30-B59A-43FA-8419-73D27CC87075

Q36820885-26B8E7B4-1B07-4AD2-88C2-8BB400D71F2A

Q36820885-29642906-81F0-4F2B-87E2-7D4F2B97C86E

Q36820885-297CB965-1ACE-48DC-BB49-52FA3E9ECB3A

P304

Q36820885-53C959C7-8BED-481E-9D68-047B01DBA740

P31

Q36820885-33598E5C-A0BB-40C4-866B-09A3B7B01EC1

P356

Q36820885-7016D674-F30C-4FBE-A877-0A4D8CC6BDCC

P433

Q36820885-B38B52AF-19E1-477E-AD92-C47542FC1B7C

P478

Q36820885-4F158374-EEE1-41F1-A93E-53C9C90ACFF0

P50

Q36820885-3AEF0BE3-65F0-4A34-9968-B6048183CAF0

Q36820885-76445E58-74E5-4F3D-8078-797B2800F88E

Q36820885-DE67DE1C-0193-4CF1-AFF6-1FE9B31BD545

P577

Q36820885-81362E4C-1F67-428A-AB60-93ABA46A8D77

P698

Q36820885-27ED8F94-BADC-4C8B-A265-06D63A49CC33

P932

Q36820885-B921BDCA-24DF-4CB6-90C2-8ACAF2ACDB79

P356

JNCCN.2014.0125

P1433

Journal of the National Comprehensive Cancer Network

P1476

Non-Hodgkin's lymphomas, version 4.2014.

@en

P2093

Andrew D Zelenetz

http://www.w3.org/2001/XMLSchema#string

Ann S LaCasce

http://www.w3.org/2001/XMLSchema#string

Auayporn Nademanee

http://www.w3.org/2001/XMLSchema#string

Ayman A Saad

http://www.w3.org/2001/XMLSchema#string

C Babis Andreadis

http://www.w3.org/2001/XMLSchema#string

Christina Tsien

http://www.w3.org/2001/XMLSchema#string

Christopher R Kelsey

http://www.w3.org/2001/XMLSchema#string

Erin Reid

http://www.w3.org/2001/XMLSchema#string

Hema Sundar

http://www.w3.org/2001/XMLSchema#string

Jeremy S Abramson

http://www.w3.org/2001/XMLSchema#string

P2860

Limited-stage mantle-cell lymphoma

A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma. The Non-Hodgkin's Lymphoma Classification Project

Bendamustine plus rituximab versus CHOP plus rituximab as first-line treatment for patients with indolent and mantle-cell lymphomas: an open-label, multicentre, randomised, phase 3 non-inferiority trial

Single-agent lenalidomide in patients with mantle-cell lymphoma who relapsed or progressed after or were refractory to bortezomib: phase II MCL-001 (EMERGE) study.

Targeting BTK with ibrutinib in relapsed or refractory mantle-cell lymphoma

Treatment of mantle-cell lymphomas with intermittent two-hour infusion of cladribine as first-line therapy or in first relapse.

Cyclophosphamide/fludarabine (CF) is active in the treatment of mantle cell lymphoma.

Multicenter phase II study of bortezomib in patients with relapsed or refractory mantle cell lymphoma.

Lenalidomide monotherapy in relapsed or refractory aggressive non-Hodgkin's lymphoma.

Phase II multicenter study of bendamustine plus rituximab in patients with relapsed indolent B-cell and mantle cell non-Hodgkin's lymphoma.

P304

1282-1303

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.6004/JNCCN.2014.0125

http://www.w3.org/2001/XMLSchema#string

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

12

http://www.w3.org/2001/XMLSchema#string

P50

William G Wierda

P577

2014-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25190696

http://www.w3.org/2001/XMLSchema#string

P932

4839265

http://www.w3.org/2001/XMLSchema#string